Craig Hospital
craighospital.orgTotal trials
35
Active
9
Phase 3
1
Total enrollment
5,962
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Acetylcholine | — | — | — | — | — | 1 | |
| Sodium Nitroprusside | — | — | — | — | — | 1 | |
| Ascorbic acid | — | — | — | — | — | 1 |
Next readouts
- 2027-03-30
Top conditions
- Spinal Cord Injuries13
- Traumatic Brain Injury8
- Spinal Cord Injury6
- Pain3
- Endothelial Dysfunction3
- Cervical Spinal Cord Injury2
- Tetraplegia2
- Osteoporosis2
Frequently asked questions about Craig Hospital
- How many clinical trials does Craig Hospital have on ClinicalTrials.gov?
- Craig Hospital is listed as the lead sponsor on 35 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Craig Hospital's trials are in Phase 3?
- 1 of Craig Hospital's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Craig Hospital focus on?
- Craig Hospital's most-studied conditions on ClinicalTrials.gov are Spinal Cord Injuries, Traumatic Brain Injury, Spinal Cord Injury, Pain, Endothelial Dysfunction.
- When are Craig Hospital's next clinical trial readouts?
- Craig Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “Role of Endothelial Function in SCI CVD Risk”, expected around 2027-03-30.